JOHNSON & JOHNSON (JNJ) vs COCA COLA CO(KO)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | JNJ | KO |
|---|---|---|
| Sector | Health Care | Consumer Staples |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $94.19B | $47.94B |
| Revenue growth (YoY) | ▲ 6.0% | ▲ 1.9% |
| Net income | $26.80B | $13.14B |
| Gross margin | 67.9% | 61.6% |
| Diluted EPS | $11.03 | $3.04 |
| Insider net (6 mo) | −40.8K sh · 6 sells · 0 buys | −674.9K sh · 21 sells · 0 buys |
| Institutional owners | 47 | 50 |
| Institutional value held | $294.77B | $187.22B |
| Next earnings (est.) | Around Oct 13, 2026 | Around Oct 20, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
About COCA COLA CO (KO)
The Coca-Cola Company, incorporated in Delaware in 1919 as successor to a Georgia corporation founded in 1892, is a global total beverage company whose products, sold in the U.S. since 1886, are now marketed in more than 200 countries and territories.
Source: SEC EDGAR.